gamer456148

Moderna's Phase 2, $90 Target Inevitable

שורט
NASDAQ:MRNA   Moderna, Inc.
First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. Moderna's Covid19 vaccine for mRNA-1273 is reaching Phase 2 clinical trails by the FDA which is further ahead than most of its small competitors and bio-pharmaceutical corporations. As always, you see the big giant crushing the small one. This news is expected to have a surge in buy signals and once it passes the $70 threshold quite soon, it will lead to a $90 short being the next actual target. That's right it can go that high, and who would be surprised?

כתב ויתור

המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.